The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn’t one of them. The 10 stocks that made the cut could ...

A Legionnaires' disease outbreak in New York's Central Harlem neighborhood has now sickened 90 people and caused three deaths ...

South Korea’s pharma industry has a valuable pool of promising drugs, but China still leads the way in out-licensing deals.

Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" providers to prescribe its ...

Jennie Finch is one of the best players in the history of her sport. The iconic University of Arizona star led the Wildcats ...

If Novo Nordisk A/S’s wildly popular weight-loss drug succeeds in a highly anticipated trial for Alzheimer’s disease, Biogen Inc.’s Chief Executive Officer Chris Viehbacher doesn’t see it as a ...

Currently, the NHS offers a range of services to help people manage their obesity, including prescription weight loss medication like Mounjaro and the NHS Digital Weight Management Programme. This is ...

This new programme is meant to make it easier for these people living with obesity to access holistic, wraparound services ...

Eli Lilly specializes in obesity and diabetes treatments, among other areas. It's reasonable to expect a lot more growth from ...

The UK government will contribute up to £50 million of new investment into the scheme, with Lilly contributing up to £35 ...

In a recent interview with Men’s Health, Alden Ehrenreich revealed that when the discussion about his role in Weapons started ...

For $1.3 billion in aggregate—including upfront and milestone payments—Bayer will get exclusive global access to Kumquat ...